However, the correlations between PD-L1 expression in tumor cells and treatment response to anti-PD-1 or anti-PD-L1 therapy is still unclear because almost 10% of patients with PD-L1-negative tumors also responded to PD-1/PD-L1 inhibitors in the above clinical trials [4,6]. Here, CD274 is linked to neoplasm.